Nolte Alexander 4
4 · Syndax Pharmaceuticals Inc · Filed Feb 3, 2023
Insider Transaction Report
Form 4
Nolte Alexander
Chief Accounting Officer
Transactions
- Award
Stock Options (Right to buy)
2023-02-02$28.55/sh+17,000$485,350→ 17,000 totalExercise: $28.55Exp: 2033-02-02→ Common Stock (17,000 underlying)
Footnotes (1)
- [F1]1/48th of the shares subject to the option shall vest monthly over a four-year period.